MRC1 and neoplasm: We observed that ILT4 knockdown in tumor cells decreased M2-like markers, including CD163, CD206, IL-10, and Arginase 1 but increased M1-like markers including CD80, CD86, IL-12, and TNFαin TAMs (Figure 3K-L, Figure S3H).